-
Purdue Pharma Says It Will Transform Into 'Public Benefit Company,' As It Files For Bankruptcy — Proposes $7.4 Billion Settlement In Opioid Case
Wednesday, March 19, 2025 - 3:34am | 517Read More...Amid the ongoing opioid crisis, Purdue Pharma has proposed a new bankruptcy plan. The pharmaceutical giant is offering a settlement of at least $7.4 billion to address its role in the crisis. What Happened: On Tuesday, the OxyContin maker submitted a revised bankruptcy plan, offering a settlement...
-
Massachusetts Attorney General Says Sacklers 'Will Be Held Responsible' After Supreme Court Vacates Purdue Bankruptcy Plan
Thursday, June 27, 2024 - 6:23pm | 562Read More...Massachusetts Attorney General Andrea Joy Campbell made it clear that her office will make sure the Sackler family that owns Purdue Pharma will make reparations to families negatively affected by the opioid epidemic, following the Supreme Court‘s 5-4 decision on Thursday to dismiss the...
-
Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
Thursday, June 27, 2024 - 12:31pm | 514Read More...The Supreme Court has rejected a bankruptcy plan for OxyContin-maker Purdue Pharma that would have allocated billions from the wealthy Sackler family to combat opioid addiction, and the Sacklers would have been shielded from civil lawsuits related to their alleged role in the opioid crisis. The 5-4...
-
Publicis To Pay $350M In First-Ever Opioid Marketing Settlement
Friday, February 2, 2024 - 7:21am | 760Read More...In a historic move, Publicis Groupe SA (OTC:PUBGY), a French advertising company, has agreed to a $350 million settlement over its alleged role in the opioid crisis. This marks the first time an advertising firm has been held accountable for its part in the epidemic. What Happened: Publicis, the...
-
Supreme Court Halts Purdue Pharma's $6B Settlement: Sackler Family's Shield From Opioid Lawsuits Challenged
Thursday, August 10, 2023 - 4:44pm | 687Read More...On Thursday, the Supreme Court temporarily blocked a $6-billion bankruptcy settlement by Purdue Pharma, the maker of the opioid OxyContin, that would shield the Sackler family from civil lawsuits related to the opioid crisis. The court also announced that it will hear a challenge to the settlement...
-
Oxford University And King's College Join Dozens Of UK Institutions Spurning Sackler Family Opioid Billions
Sunday, May 21, 2023 - 10:26pm | 549Read More...King’s College London is the latest UK institution to sever all ties with the billionaire Sackler family amid outrage over its role in the deadly opioid epidemic in the U.S. that, as of 2021, has claimed the lives of more than 106,000 people. The move comes several...
-
Netflix Is Taking On The Opioid Crisis And Billionaire Sackler Family In New Series 'Painkiller'
Tuesday, May 9, 2023 - 3:24pm | 578Read More...A fictionalized retelling of events, Netflix (NASDAQ: NFLX) upcoming series "Painkiller" is a scripted limited series that explores some of the origins and aftermath of the opioid crisis in the United States which, as of November 2021, has resulted in 106,000...
-
15 States Settle With Opioid Maker Purdue Pharma For $4.5B: 'The Most That Individuals Have Ever Paid For Breaking The Law'
Thursday, July 8, 2021 - 2:09pm | 485Read More...The 15 states that had opposed Purdue Pharma’s controversial bankruptcy plan finally landed on a deal that clears the way for a $4.5 billion settlement, reported various media outlets. As part of the deal, Purdue will release millions of documents that detail the company’s role in the...
-
OxyContin Maker Purdue Pharma's Legal Entanglement, Explained
Tuesday, March 5, 2019 - 12:16pm | 434Read More...Privately held Purdue Pharma, which has the dubious distinction of being a party to the opioid crisis in the U.S., is reportedly considering filing for Chapter 11 bankruptcy as it faces a slew of lawsuits tied to the opioid OxyContin, according to reports from Reuters and the Wall Street...
-
Collegium Rallies On 'Value-Based Contract' With Cigna; Here's What It Means
Thursday, October 5, 2017 - 12:08pm | 406Read More...Collegium Pharmaceuticals Inc (NASDAQ: COLL) shares jumped more than 13 percent on Thursday after health insurance giant CIGNA Corporation (NYSE: CI) announced it will be discontinuing coverage of Purdue Pharma’s popular opioid painkiller OxyContin. Citing safety concerns about opioid abuse...
-
Every Generation Has Its Drug: How People Are Dealing With Opioids, The New (Old) Thing
Monday, August 7, 2017 - 11:55am | 1071Read More...The state of Ohio sues pharmaceutical companies for pushing painkillers. Missouri cops carry opioid antidotes in their cars. Judges everywhere play doctor, forcing abusers to choose between anti-addiction injections or jail. And the U.S. military — which has been dealing with opioid addiction...
-
IntelliPharmaCeutics Surges After Company Reports Successful Bioequivalence Results
Thursday, January 14, 2016 - 12:57pm | 248Read More...Shares of IntelliPharmaCeutics Intl Inc (NASDAQ: IPCI), a micro-cap pharmaceutical company that manufacturers novel and generic controlled-release oral solid dosage drugs, surged higher by more than 15 percent on Thursday. IntelliPharmaCeutics announced that a bioequivalence trial of its...












